Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenkang Decoction in Chronic Renal Failure Hemodialysis Patients
NCT05631782Phase 1Completed
- Sponsor
- First People's Hospital of Zunyi
- Start
- Nov 2020
- Primary completion
- Dec 2021
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Shenkang Decoction in chronic kidney disease (CKD) (2 arms), sponsored by First People's Hospital of Zunyi. Primary endpoints: Renal function index, TCM syndrome points at 14 days and 4 more. Started Nov 2020; status: completed.
02
Drugs
Shenkang Decoction
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT05631782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05631782.